Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IIb study of RUTI with standard tuberculosis treatment
2021-003301-22Phase 2Active
- Sponsor
- Archivel Farma
- Start
- Jul 2021
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in pulmonary tuberculosis (TB) and Tuberculosis (TB) comparing RUTI plus standard treatment with Placebo plus standard treatment (2 arms). Primary endpoint: Early Bactericidal Activity (EBA). Started Jul 2021; status: active.
02
Drugs
RUTI vaccine
03
Conditions
pulmonary tuberculosis (TB)Tuberculosis (TB)
Beyond the preview
Go deeper on 2021-003301-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-003301-22.